West Pharmaceutical Services (MEX:WST) Tariff Resilience Score : 6/10 (As of Jul. 04, 2025)

View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Tariff Resilience Score?

West Pharmaceutical Services has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

West Pharmaceutical Services has West Pharmaceutical Services has a global manufacturing footprint, which exposes it to tariffs. However, its strong market position and ability to pass costs to customers provide some mitigation. Previous tariff impacts have been managed effectively.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes West Pharmaceutical Services might have Average Resilient.

Competitive Comparison of West Pharmaceutical Services's Tariff Resilience Score

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

West Pharmaceutical Services's Tariff Resilience Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Tariff Resilience Score falls into.

Save Embed

;

Save Embed

;

West Pharmaceutical Services (MEX:WST) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score	Resilience Level
7 - 10	Highly Resilient
4 - 6	Average Resilient
0 - 3	Highly Vulnerable

West Pharmaceutical Services Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (MEX:WST) » Definitions » Tariff Resilience Score

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany WPS:Germany W2ST34:Brazil

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-1147

Website

https://www.westpharma.com

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.